Keebeck Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-60
Closed -$7K – 318
2020
Q2
$7K Buy
+60
New +$7.06K ﹤0.01% 326
2020
Q1
– Sell
-10
Closed – – 293
2019
Q4
$0 Buy
+10
New +$840 ﹤0.01% 338

Other funds holding RGEN

Keebeck Wealth Management's RGEN Position: Q3 2020 in Review

Keebeck Wealth Management sold out of Repligen (RGEN) in Q3 2020, closing a stake of 60 shares — an estimated $7K sold.

Keebeck Wealth Management first reported a position in RGEN in Q4 2019 and held it in 2 quarters. The position peaked at $7K in Q2 2020. 390 funds tracked by Wall St. Rank hold RGEN as of Q3 2020.

  • Keebeck Wealth Management reported no remaining Repligen position as of Q3 2020 after selling out during the quarter.
  • Keebeck Wealth Management sold 60 Repligen shares in Q3 2020, an estimated $7K.
  • Keebeck Wealth Management first reported a position in Repligen in Q4 2019 and held it in 2 quarters.
  • Keebeck Wealth Management's Repligen position peaked at $7K in Q2 2020.
  • 390 funds tracked by Wall St. Rank held Repligen as of Q3 2020.

Based on Keebeck Wealth Management's 13F filing for Q3 2020, filed 2 Nov 2020.